Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LMR Plus is a **topical combination analgesic/anesthetic kit** marketed by V2 Pharma that contains **lidocaine** and **menthol** as active ingredients, including a **lidocaine patch 5%** component. It is used primarily for topical pain relief, especially pain associated with **post-herpetic neuralgia**, and has also been associated in source context with broader minor musculoskeletal and neuropathic pain uses typical of lidocaine and menthol topical products. Mechanistically, lidocaine is a small-molecule **local anesthetic** that reduces pain signaling by blocking voltage-gated sodium channels in peripheral nerves, while menthol provides cooling or warming counterirritant effects via thermosensory signaling that helps modulate local pain perception. The available source text indicates this product is marketed but also notes that its labeling states it has **not been found by FDA to be safe and effective and has not been approved by FDA**.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on LMR Plus.